Two graphsPosted: February 14, 2012
Via Drug Monkey. I just puked in my mouth a little.
First off, apparently the NIH considers “leveling off at 42” some kind of win, when we all know that what really happened is that when they starting prioritizing early-stage investigators, study sections (dominated by old people) started ratfucking the scores of early stage investigators.
We all know how science goes forward, and I’m not going to nearly enough funerals.